Pharmlog Pharma Logistik

Pharmlog Pharma Logistik's reported carbon emissions

Pharmlog Pharma Logistik GmbH, headquartered in Germany and operating within sea and coastal water transportation services, has demonstrated its commitment to reducing its environmental impact. In 2023, the company reported total greenhouse gas (GHG) emissions of approximately 4.7 million kg CO2e. This figure comprises Scope 1 emissions of about 389,200 kg CO2e, Scope 2 emissions of approximately 1,017 kg CO2e, and Scope 3 emissions totalling around 4.3 million kg CO2e. The breakdown of Scope 3 emissions in 2023 includes significant contributions from downstream transportation and distribution (approximately 3.2 million kg CO2e) and purchased goods and services (around 650,000 kg CO2e), alongside employee commute (approximately 298,700 kg CO2e), fuel and energy-related activities (about 104,700 kg CO2e), and waste generated in operations (approximately 34,500 kg CO2e), and upstream transportation and distribution (around 3,300 kg CO2e), and business travel (approximately 600 kg CO2e). In 2022, Pharmlog Pharma Logistik GmbH's total emissions were approximately 6.7 million kg CO2e, with Scope 1 emissions at about 348,300 kg CO2e, Scope 2 emissions at approximately 1,085 kg CO2e, and Scope 3 emissions totalling around 6.3 million kg CO2e. The Scope 3 components for 2022 included downstream transportation and distribution (approximately 5.1 million kg CO2e), purchased goods and services (about 730,700 kg CO2e), employee commute (around 319,900 kg CO2e), fuel and energy-related activities (approximately 111,100 kg CO2e), waste generated in operations (around 35,200 kg CO2e), upstream transportation and distribution (about 5,000 kg CO2e), and business travel (around 400 kg CO2e). For 2021, the company reported total GHG emissions of approximately 6.5 million kg CO2e, with Scope 1 emissions at around 424,500 kg CO2e, Scope 2 emissions at approximately 1,089 kg CO2e, and Scope 3 emissions totalling about 6.1 million kg CO2e. The Scope 3 emissions in 2021 were primarily driven by downstream transportation and distribution (approximately 4.9 million kg CO2e) and purchased goods and services (around 678,500 kg CO2e), with employee commute at about 350,100 kg CO2e, fuel and energy-related activities at approximately 131,000 kg CO2e, waste generated in operations at around 38,400 kg CO2e, upstream transportation and distribution at about 4,700 kg CO2e. Pharmlog Pharma Logistik GmbH has established a significant climate commitment through its alignment with the Science Based Targets initiative (SBTi). As a small or medium-sized enterprise (SME), the company commits to a 46% reduction in Scope 1 and Scope 2 GHG emissions by 2030, using 2019 as the base year. This target is considered consistent with limiting global warming to 1.5°C. The company also commits to measuring and reducing its Scope 3 emissions. These SBTi targets were approved via a streamlined route for SMEs and are cascaded from the ultimate parent company, Pharmlog Pharma Logistik GmbH itself, as indicated by cascade level 0 for SBTi initiatives.